Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.080
+0.050 (4.85%)
At close: Oct 8, 2024, 4:00 PM
1.040
-0.040 (-3.70%)
After-hours: Oct 8, 2024, 5:00 PM EDT
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 41 employees as of December 31, 2023. The number of employees increased by 3 or 7.89% compared to the previous year.
Employees
41
Change (1Y)
3
Growth (1Y)
7.89%
Revenue / Employee
n/a
Profits / Employee
-$607,707
Market Cap
8.73M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41 | 3 | 7.89% |
Dec 31, 2022 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Vivos Therapeutics | 123 |
Check-Cap | 85 |
Mustang Bio | 80 |
NeuroMetrix | 26 |
Addex Therapeutics | 23 |
Plus Therapeutics | 20 |
Purple Biotech | 20 |
Quantum BioPharma | 17 |
CLDI News
- 2 months ago - Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 2 months ago - GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor - GlobeNewsWire
- 2 months ago - Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform - GlobeNewsWire
- 3 months ago - Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board - GlobeNewsWire
- 3 months ago - Calidi to Effect Reverse Stock Split - Business Wire
- 3 months ago - Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors - Business Wire
- 4 months ago - Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13 - Business Wire